Not available
Quote | Merrimack Pharmaceuticals Inc. (NASDAQ:MACK)
Last: | $14.72 |
---|---|
Change Percent: | 0.0% |
Open: | $14.68 |
Close: | $14.72 |
High: | $14.73 |
Low: | $14.68 |
Volume: | 76,084 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
News | Merrimack Pharmaceuticals Inc. (NASDAQ:MACK)
2024-04-13 01:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-27 16:36:45 ET More on Merrimack Pharmaceuticals Merrimack spikes as Ipsen wins FDA label expansion for cancer therapy Financial information for Merrimack Pharmaceuticals Read the full article on Seeking Alpha For further details see: Merrimack re...
Message Board Posts | Merrimack Pharmaceuticals Inc. (NASDAQ:MACK)
Subject | By | Source | When |
---|---|---|---|
Nice! | cjstocksup | investorshub | 11/11/2022 2:52:27 AM |
Closed $12.80 aftermarket. up 3% and just under | subslover | investorshub | 11/11/2022 1:23:16 AM |
Holding perfect. | cjstocksup | investorshub | 11/10/2022 7:52:09 PM |
Very little profit taking. She could take off | subslover | investorshub | 11/10/2022 3:10:34 PM |
If I am awake, I begin looking at | cjstocksup | investorshub | 11/10/2022 12:58:25 AM |
News, Short Squeeze, Breakout and More Instantly...
Merrimack Pharmaceuticals Inc. Company Name:
MACK Stock Symbol:
NASDAQ Market:
2024-04-13 01:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Special Meeting of Stockholders to Approve Plan of Dissolution Scheduled for Friday, May 10, 2024 at 10:00 a.m. Eastern Standard Time Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) (“Merrimack” or the “Company”) today announced that it has received a $225 mil...
Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 0.2% on the day to $14.82. Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorpora...